Jobs / United States / Gilead Sciences INC
Assoc Director, End-to-End Commercial Supply Chain Planner
Gilead Sciences INC · 🇺🇸 United States - California - Foster City
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Gilead Sciences INC paid sponsored hires in similar roles2 certified filings for “Exec Director, Supply Chain” (General and Operations Managers) in CA: $229k–$264k, median $247k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Gilead Sciences INC
The US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Gilead Sciences INC →
About the role
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference. Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact. We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together. Job Description Job Description At Gilead our pursuit of a healthier world for all people has yielded a cure for hepatitis C, revolutionary improvements in HIV treatment and prevention as well as advancements in therapies for viral and inflammatory diseases and certain cancers. We set and achieve bold ambitions in our fight against the world’s most devastating diseases, united in our commitment to confronting the largest public health challenges of our day and improving the lives of patients for generations to come. The Associate Director, End-to-End Commercial Supply Planner plays a critical role in developing and executing supply plans for commercial small molecule and biologics products. This role partners closely with regional commercial supply chain leads to deeply understand demand planning trends, market dynamics, and promotional activities, ensuring these inputs are fully incorporated into global supply plans. Reporting to the End-to-End Commercial Supply Chain Product Lead, the role leverages tools such as SAP ERP and Kinaxis Rapid Response to enable accurate, responsive supply planning and ensure product availability across diverse markets. Key Responsibilities: Collaborative Demand-Supply Alignment: • Act as a primary partner to regional commercial supply chain leads to understand regional demand planning trends, market access changes, promotional campaigns, and product lifecycle events. • Ensure demand signals from regional planning teams are accurately reflected and integrated into the end-to-end supply plans (API, Drug Substance, Drug Product, Finished Goods) to enable interrupted supply to global markets. • Facilitate regular communication and alignment sessions with regional leads to validate assumptions, reconcile forecast discrepancies, and adjust supply plans accordingly. Supply Planning & Execution: • Develop, maintain, and execute detailed commercial supply plans across API, Drug Substance, Drug Product, and Finished Goods, integrating demand insights, manufacturing capacities, end to end lead times, and minimum remaining shelf life (MRSL) requirements at both batch release and market delivery to ensure compliant and timely supply. • API Detailed Planning includes: • Review Part Setups, effective dates & other master data • Monitor new product supply setup updates • Manage the API Retest & Expiry Review • Review and manage MoH across API • Manage system FPOs, including allocation of ICNs\ • Review Demand & Drug Product Supply Plan outliers • Review DP 5 Year Supply Plan & API 4 Year Supply Plan • Review API Inventory Health • Create first draft SRM API Change An